YOUR BUSINESS AUTHORITY
Springfield, MO
AbbVie signed on to buy rival drugmaker Allergan for $63 billion.
The bid values Allergan's shares at a 45% premium.
The acquisition would combine AbbVie, the maker of arthritis drug Humira, and Allergan, which is known for its wrinkle treatment Botox, among other products.
Read more from Bloomberg.
Evergreen Hair House opened; the Ozark Chamber of Commerce moved to a new home; and Dirk’s Tavern LLC got its start on C-Street.
Missouri man sentenced for PPP fraud
Updated: First Watch business partner sues another for breach of fiduciary duty, fraud
Wendy’s franchisee ordered to pay $7M over harassment, PPP fraud accusations
Palm & Paddle Grille aims for mid-June launch
Home construction companies merge to launch new venture
Four businesspeople join United Way board
Physician sues CoxHealth, alleging business interference and defamation